NOMURA ASSET MANAGEMENT INTERNATIONAL INC.
Position in RDY — Dr Reddys Laboratories Ltd
CIK 921739
PHILADELPHIA, PA
Position in RDY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,121,406
+$444,482 QoQ
Shares Held
80,968
+67.9% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026NOMURA ASSET MANAGEMENT INTERNATIONAL INC. holds $393,367,916 across 13 Drug Manufacturers - Specialty & Generic names. RDY ranks #13 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SUPN |
Supernus Pharmaceuticals, Inc.
|
2,037,202 | $105,302,971 | |
| 2 | ZTS |
Zoetis Inc.
|
590,089 | $69,754,420 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
840,417 | $63,745,629 | |
| 4 | PBH |
Prestige Consumer Healthcare Inc.
|
1,070,515 | $63,449,424 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
195,741 | $25,786,919 | |
| 6 | ANIP |
Ani Pharmaceuticals Inc
|
287,563 | $22,113,594 | |
| 7 | VTRS |
Viatris Inc
|
1,305,217 | $17,633,481 | |
| 8 | ALKS |
Alkermes plc.
|
339,998 | $12,022,329 |
All Filings in RDY
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,121,406 | 80,968 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $676,924 | 48,214 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||